For the year ending 2025-12-31, ENOV had -$11,778K decrease in cash & cash equivalents over the period. $19,917K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -1,183,620 |
| Goodwill and asset impairment | 1,049,751 |
| Depreciation and amortization | 294,378 |
| Stock-based compensation expense | 32,922 |
| Non-cash interest expense | 7,378 |
| Fair value gain on contingency shares | 1,787 |
| Unrealized loss (gain) on currency hedges | 0 |
| Debt extinguishment charges | 0 |
| Deferred income tax expense (benefit) | -2,226 |
| (gain) loss on sale of property, plant and equipment | -1,458 |
| Trade receivables, net | 10,752 |
| Inventories, net | 11,981 |
| Accounts payable | -1,137 |
| Other operating assets and liabilities | -39,335 |
| Net cash provided by operating activities | 217,293 |
| Purchases of property, plant and equipment and intangibles | 197,376 |
| Proceeds from sale of property, plant and equipment | 0 |
| Payments for acquisitions, net of cash received, and investments | 26,859 |
| Proceeds from sale of business, net | 43,263 |
| Cash received (paid) for settlement of derivative | -1,601 |
| Net cash used in investing activities | -179,371 |
| Proceeds from borrowings on term credit facility | 335,000 |
| Repayments of borrowings under term credit facility | 23,750 |
| Proceeds from borrowings on revolving credit facilities and other | 209,000 |
| Repayments of borrowings on revolving credit facilities and other | 557,175 |
| Proceeds from borrowings on senior unsecured convertible notes | 0 |
| Payment of debt issuance costs | 6,674 |
| Proceeds from issuance of common stock, net | 1,318 |
| Payment of capped call transactions | 0 |
| Payments of tax withholding for stock-based awards | 3,504 |
| Deferred consideration payments and other | -6,615 |
| Net cash provided by (used in) financing activities | -52,400 |
| Effect of foreign exchange rates on cash and cash equivalents | 2,700 |
| Increase (decrease) in cash and cash equivalents and restricted cash | -11,778 |
| Cash and cash equivalents and restricted cash, beginning of period | 48,167 |
| Cash and cash equivalents and restricted cash, end of period | 36,389 |
Enovis CORP (ENOV)
Enovis CORP (ENOV)